“Manipulating epigenetic regulators to enable immune checkpoint blockade”
Dr Yang Shi is a Professor of Cell Biology at Harvard Medical School and a noted leader in the field of histone demethylases. He discovered and characterized LSD1, the first histone demethylase to be identified, and has made key contributions to the understanding of epigenetic modifications, gene regulation and diseases such as X-linked mental retardation and cancer. He was elected to the American Academy of Arts and Sciences in 2016.
Date:
3 June 2019, 11:00 (Monday, 6th week, Trinity 2019)
Venue:
NDM Building, Headington OX3 7FZ
Venue Details:
TDI seminar room
Speaker:
Professor Yang Shi (Harvard Medical School)
Organising department:
Ludwig Institute for Cancer Research, Oxford Branch
Organiser:
Alexandra Ward (University of Oxford, Oxford Ludwig Institute, NDM Experimental Medicine)
Host:
Prof Xin Lu (Ludwig Cancer Research, Oxford Branch)
Part of:
Ludwig Institute Seminar Series
Topics:
Booking required?:
Not required
Audience:
Members of the University only
Editor:
Alexandra Royer
